Looking to the Horizon: Emerging Therapies and the Near Future Evolution in Prostate Cancer

Gain expert insights on emerging therapies in prostate cancer with downloadable slidesets from a satellite sympoisum, an on-demand webcast, and an expert commentary.

Share

Program Content

Activities

PARPi in mCRPC
PARP Inhibitors: Fitting into the Treatment Landscape
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 17, 2023

Expires: February 16, 2024

PSMA Targeting
PSMA and Other Prostate Antigen Targeting
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 17, 2023

Expires: February 16, 2024

Investigational Targets
Emerging Investigational Targets and Combinations in mCRPC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 17, 2023

Expires: February 16, 2024

Activities

Emerging Therapies in mCRPC
Looking to the Horizon: Emerging Therapies and the Near Future Evolution in Prostate Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 28, 2023

Expires: March 27, 2024

Activities

FAQs: Emerging Prostate Cancer Therapies
Emerging Therapies and the Near Future Evolution in Prostate Cancer: Expert Discussion of Frequently Asked Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 01, 2023

Faculty

cover img faculity

Neeraj Agarwal, MD

Professor of Medicine
Senior Director for Clinical Research, Huntsman Cancer Institute (HCI)
Presidential Endowed Chair of Cancer Research
Director, Center of Investigational Therapeutics
Director, Genitourinary Oncology Program
Huntsman Cancer Institute, University of Utah (NCI-CCC)
Salt Lake City, Utah

cover img faculity

Tanya B. Dorff, MD

Professor of Medicine
Vice Chair for Clinical Affairs
Department of Medical Oncology
City of Hope National Medical Center
Duarte, California

cover img faculity

Rana R. McKay, MD

Associate Professor of Medical Oncology and Urology
Associate Director, Clinical Sciences
Co-Lead, Genitourinary Malignancies Program
Moores Cancer Center
University of California San Diego
La Jolla, California

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from

Exelixis, Inc.

Lilly

Pfizer, Inc.